"Designing Growth Strategies is in our DNA"

Bleeding Disorder Testing Market Size, Share, Growth & COVID-19 Impact Analysis, By Product Type (Reagents & Consumables and Instruments), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106908

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Forecast Period

2023-2030

Historical Period

2019-2021

Unit

Value (USD Million)

Growth Rate

CAGR of 7.9% from 2023-2030

Segmentation

By Product Type, Indication, End-user, and Region

By Product Type

  • Reagents & Consumables
  • Instruments

By Indication

  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Idiopathic Thrombocytopenic Purpura
  • Others

By End-user

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Rest of the World
  • 2019-2030
  • 2022
  • 2019-2021
  • 130
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase